[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  David Smith [@DavidSmithX1](/creator/twitter/DavidSmithX1) on x 3725 followers Created: 2025-07-18 12:26:18 UTC BREAKING: GSK $GSK plunges after its key blood cancer drug faces likely rejection in the U.S., triggering concerns across the biotech space. Expect heavy volume and sector volatility. Watch Opendoor $OPEN, Coca-Cola $KO, and Okta $OKTA for potential spillover moves.  XXX engagements  **Related Topics** [$okta](/topic/$okta) [okta](/topic/okta) [$gsk](/topic/$gsk) [gsk plc](/topic/gsk-plc) [stocks healthcare](/topic/stocks-healthcare) [open opendoor technologies inc](/topic/open-opendoor-technologies-inc) [$open](/topic/$open) [$ko](/topic/$ko) [Post Link](https://x.com/DavidSmithX1/status/1946184754178433304)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
David Smith @DavidSmithX1 on x 3725 followers
Created: 2025-07-18 12:26:18 UTC
BREAKING: GSK $GSK plunges after its key blood cancer drug faces likely rejection in the U.S., triggering concerns across the biotech space.
Expect heavy volume and sector volatility. Watch Opendoor $OPEN, Coca-Cola $KO, and Okta $OKTA for potential spillover moves.
XXX engagements
Related Topics $okta okta $gsk gsk plc stocks healthcare open opendoor technologies inc $open $ko
/post/tweet::1946184754178433304